JPS5340798A - Production of substituted phenyll1*2*44triazolo *4*33b* pyrodazines * acid addition salt and treating composition - Google Patents

Production of substituted phenyll1*2*44triazolo *4*33b* pyrodazines * acid addition salt and treating composition

Info

Publication number
JPS5340798A
JPS5340798A JP11344877A JP11344877A JPS5340798A JP S5340798 A JPS5340798 A JP S5340798A JP 11344877 A JP11344877 A JP 11344877A JP 11344877 A JP11344877 A JP 11344877A JP S5340798 A JPS5340798 A JP S5340798A
Authority
JP
Japan
Prior art keywords
pyrodazines
phenyll1
44triazolo
substituted
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11344877A
Other languages
English (en)
Japanese (ja)
Inventor
Rojiyaa Aren Jiyunia Jiyooji
Uiriamu Hanifuin Jiyunia Jiyon
Buraian Moran Danieru
Donarudo Aruburaito Jiei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/725,597 external-priority patent/US4230705A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of JPS5340798A publication Critical patent/JPS5340798A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/08Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP11344877A 1976-09-22 1977-09-22 Production of substituted phenyll1*2*44triazolo *4*33b* pyrodazines * acid addition salt and treating composition Pending JPS5340798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/725,597 US4230705A (en) 1976-09-22 1976-09-22 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
US73039576A 1976-10-07 1976-10-07
US73547576A 1976-10-26 1976-10-26

Publications (1)

Publication Number Publication Date
JPS5340798A true JPS5340798A (en) 1978-04-13

Family

ID=27419081

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11344877A Pending JPS5340798A (en) 1976-09-22 1977-09-22 Production of substituted phenyll1*2*44triazolo *4*33b* pyrodazines * acid addition salt and treating composition

Country Status (19)

Country Link
JP (1) JPS5340798A (de)
AR (2) AR218036A1 (de)
AT (1) AT360034B (de)
AU (1) AU513760B2 (de)
BG (1) BG29287A3 (de)
CA (1) CA1080712A (de)
DD (1) DD132586A5 (de)
DE (1) DE2741763A1 (de)
DK (1) DK417377A (de)
ES (3) ES462543A1 (de)
FI (1) FI772802A (de)
FR (1) FR2442848A1 (de)
GB (1) GB1589237A (de)
GR (1) GR71699B (de)
LU (1) LU78150A1 (de)
NL (1) NL7710389A (de)
NO (1) NO773245L (de)
PT (1) PT67067B (de)
RO (1) RO72226A (de)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011178806A (ja) * 2004-02-18 2011-09-15 Msd Kk 含窒素縮合ヘテロ芳香環誘導体
JP2019535838A (ja) * 2016-11-28 2019-12-12 プラクシス プレシジョン メディシンズ, インコーポレイテッド 化合物及びその使用方法
US11505554B2 (en) 2019-05-31 2022-11-22 Praxis Precision Medicines, Inc. Substituted pyridines as ion channel modulators
US11731976B2 (en) 2018-05-30 2023-08-22 Praxis Precision Medicines, Inc. 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator
US11773099B2 (en) 2019-05-28 2023-10-03 Praxis Precision Medicines, Inc. Compounds and their methods of use

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR70309B (de) * 1979-10-29 1982-09-08 Dow Chemical Co
FR2473522A1 (fr) * 1980-01-16 1981-07-17 Synthelabo Nouveaux derives substitues de dihydro-2,3 imidazo(1,2-b)pyridazines et les medicaments, utiles notamment comme antidepresseurs, qui en contiennent
EP0036711B1 (de) * 1980-03-22 1985-12-04 Fbc Limited Heterocyclische pestizide Verbindungen, Verfahren zu ihrer Herstellung, sie enthaltende Zusammensetzungen und ihre Verwendung
DE3217325A1 (de) * 1982-05-08 1983-11-10 Hoechst Ag, 6230 Frankfurt 3-amino-6-aryl-1,2,4-triazolo(4,3-b)-pyridazine, ihre herstellung und ihre verwendung
US4487930A (en) * 1982-09-07 1984-12-11 The Dow Chemical Company 6-[(Cyclic amino)alkylamino]-tetrahydrotriazolo[3,4-a]phthalazines
FR2562071B1 (fr) * 1984-03-30 1986-12-19 Sanofi Sa Triazolo(4,3-b)pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant
US4654343A (en) * 1985-10-31 1987-03-31 American Cyanamid Company N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
US4767765A (en) * 1985-10-31 1988-08-30 American Cyanamid Company N-substituted-N-[3-(1,2,4-triazolo-[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
CZ18199A3 (cs) * 1996-07-25 1999-06-16 Merck Sharp And Dohme Limited Triazolopyridazinové deriváty, způsob výroby a farmaceutický prostředek
WO1999036423A1 (en) * 1998-01-14 1999-07-22 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for gaba receptors
CZ290883B6 (cs) 1998-01-21 2002-11-13 Merck Sharp And Dohme Limited Triazolopyridazinové deriváty, způsob jejich výroby a farmaceutický prostředek je obsahující
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801210D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801202D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801234D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011178806A (ja) * 2004-02-18 2011-09-15 Msd Kk 含窒素縮合ヘテロ芳香環誘導体
JP2019535838A (ja) * 2016-11-28 2019-12-12 プラクシス プレシジョン メディシンズ, インコーポレイテッド 化合物及びその使用方法
JP2022141773A (ja) * 2016-11-28 2022-09-29 プラクシス プレシジョン メディシンズ, インコーポレイテッド 化合物及びその使用方法
US11731976B2 (en) 2018-05-30 2023-08-22 Praxis Precision Medicines, Inc. 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator
US11731978B2 (en) 2018-05-30 2023-08-22 Praxis Precision Medicines, Inc. 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator
US11866439B2 (en) 2018-05-30 2024-01-09 Praxis Precision Medicines, Inc. Ion channel modulators
US11773099B2 (en) 2019-05-28 2023-10-03 Praxis Precision Medicines, Inc. Compounds and their methods of use
US11505554B2 (en) 2019-05-31 2022-11-22 Praxis Precision Medicines, Inc. Substituted pyridines as ion channel modulators

Also Published As

Publication number Publication date
ES477799A1 (es) 1980-04-01
BG29287A3 (en) 1980-10-15
GB1589237A (en) 1981-05-07
ATA677577A (de) 1980-05-15
PT67067B (en) 1979-02-19
FR2442848A1 (fr) 1980-06-27
DE2741763A1 (de) 1978-03-23
NO773245L (no) 1978-03-28
AT360034B (de) 1980-12-10
AR217886A1 (es) 1980-04-30
PT67067A (en) 1977-10-01
ES477800A1 (es) 1979-10-16
AR218036A1 (es) 1980-05-15
DD132586A5 (de) 1978-10-11
LU78150A1 (de) 1978-01-23
DK417377A (da) 1978-03-23
GR71699B (de) 1983-06-21
FI772802A (fi) 1978-03-23
AU2899577A (en) 1979-03-29
ES462543A1 (es) 1979-06-16
NL7710389A (nl) 1978-03-28
AU513760B2 (en) 1980-12-18
CA1080712A (en) 1980-07-01
RO72226A (ro) 1982-09-09

Similar Documents

Publication Publication Date Title
JPS5340798A (en) Production of substituted phenyll1*2*44triazolo *4*33b* pyrodazines * acid addition salt and treating composition
JPS569382A (en) Electrolysis production of trichloropicolic acid and * or 3*66dichloropicolic acid
JPS532477A (en) Production of nnmethylpyperizinee 22carboxylic acid 2*66 xylide hydrochloride salt
JPS525779A (en) 100*omegaa*benzoylpiperidinyl* phenothiadiazine and acid addition salt and preparation method thereof
JPS5629561A (en) Manufacture of 4*4**dinitrostylbenee2*2** disulfonic acid and its salt
JPS5495573A (en) Manufacture of 3*44methylene dioxymandelic acid
JPS5337676A (en) Production of 22*44 aloylpiperazinee11yl**44aminoo 6*77dimethoxyquinazolines
JPS539789A (en) Production of 55*22floyl** * 55*22thenoyl** * 55*33 floyl** and 55*33thenoyl** 1*22dihydroo3hhpyroro * 1*22a*pyrolee11carboxylic acid derivative
JPS5231047A (en) Production of novel 2*33 dihalogennalkanoyllurea and use of same as pesticide
JPS535150A (en) Production of 17 betaa hydroxyy33oxoo17 alphaa pregnn44enn211carboxylic acid gammaalaltone
JPS52100451A (en) Process for manufacture of 2*22dimethyll33 *2*22dichlorovinyl**cyclopropanee11carboxylic acid
JPS51143658A (en) Production of 55*2*22 dihalovynyl**4*44dimethyll 22oxotetrafuran
JPS5359694A (en) Production of sstriazoloo *1*55a**pyridinee22yll5*77 dimethyllphosphoric acid derivative and harmful organism combaiting agent containing same
JPS523093A (en) Production of 66aminopencillanic acid and 77 aminodexethoxycephalospolanic acid derivative
JPS5337651A (en) Production of novel 2*22 dimethyll199norsteroid and pharmaceutical composition
JPS5668667A (en) Manufacture of 11*44chlorobenzoyl**55methoxyy 22methyll33indolylacetoxyacetic acid
JPS5350173A (en) Production of 2*33 cycloalkenopyridine
JPS5233644A (en) Production of 11aminobenzoll 55betaasulfatoethyl sulfonee 22sulphonic acid or 11 aminobenzoll55vynylsulfonee 22sulphonic acid and alkalineeor alkaline earth salts thereof*
JPS54145283A (en) Production of 2*55 diketogluconic acid
JPS5610196A (en) Manufacture of 77*22aminomethylphenylacetoamido** 33*11carboxymethyltetrazoll55yllthiomethyl** 33cephemm44carboxylic acid
JPS52122357A (en) Production of 17 alphaa hydroxyycardenonideeglycoside and cardiac agent
JPS52108971A (en) Production of 33aminoo1*22 benzoisothiazol
GR60038B (en) Preparation process of calcium salt of 2,5-dihydroxybenzenesulphonic acid
JPS562931A (en) Manufacture of transs3*33dimethylcyclopropanee 1*22dicaboxylic acid
JPS5359689A (en) Production of 77 aminocedhalosporanic acid derivative